AI In Regulated Industries: Life Sciences Implementation And Audit Readiness

AI has moved from a distant concept to an urgent priority in life sciences, and quality teams are being asked to interpret its impact faster than ever. Technology leaders see enormous potential—from AI copilots that streamline investigations to tools that transform raw content into usable work instructions. Yet quality and regulatory teams face the harder question: How do we ensure these tools can withstand audit scrutiny? With AI evolving faster than compliance frameworks can adapt, many organizations find themselves stalled not because the technology isn’t ready, but because the culture isn’t. Leaders from medtech, biotech, and compliance organizations describe hesitation around defining intended use, selecting early use cases, and building control frameworks that feel defensible.

This article breaks down how senior leaders across Smith+Nephew, Vericel, Getinge, and Compliance Group Inc. are approaching AI adoption with both innovation and audit readiness in mind. Explore their insights and practical steps for moving forward with confidence.